HDAX Therapeutics
PrivateLast Round
Seed
Sep 5, 2024
Total Funding Raised
$4.02M
Company Overview
HDAX Therapeutics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Seed round in September 2024.
HDAX Therapeutics is a biotechnology company developing small molecule therapeutics targeting HDAC6 for the treatment of neurological and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HDAX Therapeutics Comparables
Compare HDAX Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eikonizo Therapeutics | 89% | |
| Augustine Therapeutics | 83% | |
| Regenacy Pharmaceuticals | 79% |
For institutional investors. Book with your work email.
HDAX Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2024 | ||||
| Grant | Jul 8, 2024 | ||||
| Grant | Nov 13, 2023 | ||||
| Grant | Oct 12, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HDAX Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SeedFolio | Seed |
| TIAP | Seed |
| FACIT | Seed |
| Eos | Seed |
| Ontario Centre of Innovation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Open roles tripled to 3, representing 21% of headcount.
For institutional investors. Book with your work email.
HDAX Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HDAX Therapeutics's valuation, stock price, and market status.
Is HDAX Therapeutics a public or private company?
HDAX Therapeutics is a private company.
What is the current stock price of HDAX Therapeutics?
HDAX Therapeutics is a private company, so its shares have no public market price. Caplight tracks HDAX Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HDAX Therapeutics worth (valuation)?
Valuation information for HDAX Therapeutics is not publicly available.
Can I buy HDAX Therapeutics stock?
HDAX Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HDAX Therapeutics's last funding round?
HDAX Therapeutics's most recent funding round was Seed on September 5, 2024.
Who are the main investors in HDAX Therapeutics?
Key investors in HDAX Therapeutics include SeedFolio, TIAP, FACIT.
Will HDAX Therapeutics IPO soon?
No public IPO plans have been announced for HDAX Therapeutics.
How can I track HDAX Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in HDAX Therapeutics's shares on secondary markets.